Paratus Sciences Appoints Alicia Secor as Chief Executive Officer and Jeffrey Young as Chief Financial Officer
Position
Chief Financial Officer
Company
Paratus Sciences Corporation
New YorkBiotechnologyHealth CareArtificial IntelligenceTherapeuticsBiotechnology ResearchDescription
Paratus Sciences has announced the appointment of Alicia Secor as President and Chief Executive Officer, along with Jeffrey Young as Chief Financial Officer. These appointments are part of a strategy to enhance the leadership team and advance their therapeutic candidate PS-1001 towards first-in-human studies.
Quick answer
Paratus Sciences Appoints Alicia Secor as Chief Executive Officer and Jeffrey Young as Chief Financial Officer (April 22, 2026). Paratus Sciences Corporation is based in New York, New York, United States.
- Who is the new Chief Financial Officer at Paratus Sciences Corporation?
- Paratus Sciences Corporation named Jeffrey Young Chief Financial Officer, announced April 22, 2026.
- What did Paratus Sciences Corporation announce on April 22, 2026?
- Paratus Sciences has announced the appointment of Alicia Secor as President and Chief Executive Officer, along with Jeffrey Young as Chief Financial Officer. These appointments are part of a strategy to enhance the leadership team and advance their therapeutic candidate PS-1001 towards first-in-human studies.
- What does Paratus Sciences Corporation do?
- We believe that bats hold the key to a safer and healthier world.
- Where is Paratus Sciences Corporation based?
- Paratus Sciences Corporation is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- BPGbio (April 21, 2026), Recursion Pharmaceuticals (March 25, 2026), Change Agents Corporation. (June 4, 2026) and BridgeBio Oncology Therapeutics (April 22, 2026) also announced leadership changes within 45 days of Paratus Sciences Corporation.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology Research
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- BPGbio Appoints Chas Bountra as Executive Vice President and Chief Science Officer (April 21, 2026)
- Recursion Pharmaceuticals Appoints Vicki Goodman, M.D., as Chief Medical Officer (March 25, 2026)
- Avalon Appoints Sam Knipper as Chief Financial Officer (June 4, 2026)
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
- Jade Biosciences Appoints Edward R. Conner, M.D. as Chief Medical Officer (April 23, 2026)
- Formedics Appoints Steve Gordon as Chief Legal Officer (April 21, 2026)
Who to call at Paratus Sciences Corporation, and when
A new leader at Paratus Sciences Corporation brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Paratus Sciences Corporation raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Paratus Sciences Corporation, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Paratus Sciences Corporation. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Paratus Sciences Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Paratus Sciences Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.